CARRIE MCGUIRE: Open Payments
NPI 1104988138 · GUTHRIE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 69 payments from 19 companies in 2025. Trend: 2023 $902 · 2024 $809 · 2025 $1,355
Food & beverage: $1,355
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $229 |
| PFIZER INC. | 12 | $163 |
| Novo Nordisk Inc | 10 | $151 |
| Janssen Pharmaceuticals, Inc | 1 | $141 |
| Lilly USA, LLC | 7 | $140 |
| AstraZeneca Pharmaceuticals LP | 3 | $135 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $35 |
Products named: SPRAVATO, MOUNJARO, NURTEC ODT, AIRSUPRA, UBRELVY, GEMTESA, Wegovy, Ozempic.
Industry payments across OK — which companies pay providers there.
